FindTrial
Sign In

Usage of Orange Peel Extract in Management of Epistaxis

The Potential of Nano-based Gel of Orange Peel Extract in Management of Epistaxis : a Randomized Double Blind Clinical Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06836102
Enrollment
60
Registered
2025-02-20
Start date
2025-02-28
Completion date
2025-05-31
Last updated
2025-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epistaxis

Brief summary

Efficacy of orange peel extract in treatment of epistaxis in children

Detailed description

Formulation of orange peel extract into gel substance and usage of it in local treatment of epistaxis

Interventions

DIETARY_SUPPLEMENTOrange

usage of orange peel extract in gel layer in treatment of epistaxis

Sponsors

Minia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
5 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* children with anterior epistaxis from little's area

Exclusion criteria

* patient with nasal polyp. * patients with hematological abnormalities. * patients with general diseases affecting coagulation system.

Design outcomes

Primary

MeasureTime frameDescription
The potential of nano-based gel of Orange peel extract in management of epistaxisFrom enrollment to the end of treatment at 4 weeksassessment of epistaxis ( amount, severity and frequency ) according to ESS ( Epistaxis Severity Score ) between patients in study groups

Contacts

Primary ContactMostafa Nasr Ahmed, consultant
drmostafanasr1988@gmail.com+201007905656
Backup ContactHanaa Bahaa El-khouly, consultant of pharmacognosy
hanaa.bahaaelkhouly@yahoo.com+201001616758

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026